What does Lipocine Inc. (LPCN) do?

Lipocine Inc. (LPCN) is a publicly traded company in the Healthcare sector.

What sector does LPCN operate in?

Lipocine Inc. operates in the Healthcare, specifically within the Biotechnology industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find LPCN earnings analysis?

AlphaOS publishes an earnings intelligence page for Lipocine Inc. (LPCN) covering results, guidance context, and AI-assisted analysis. See /stocks/LPCN/earnings. Content is for research and education — not investment advice.

LPCN

Lipocine Inc.

Healthcare · Biotechnology

$2.16Sep 29, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Lipocine Inc. shows decelerating business momentum based on AlphaOS pipeline evidence, with mixed management execution.

Why it matters: Revenue -69% YoY in Q2 FY2026.

TrajectoryDecelerating

ExecutionMixed

2 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue -69% YoY in Q2 FY2026

Pipeline evidence · 0d ago

LPCN's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on LPCN.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full LPCN earnings analysis

Reported figures for Lipocine Inc. — research only, not investment advice.

Revenue YoY: -69.5%
EPS YoY: -100.0%

Latest Intelligence

Updated September 30, 2026

What happened recently for Lipocine Inc. (LPCN) — events, not interpretation.

Event: Reported Q2 2026 revenue -70% YoY.
Also: Last session September 29, 2026 at $2.16.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Lipocine Inc. (LPCN)

Healthcare · Biotechnology

Investment Snapshot above is the primary AlphaOS analysis for Lipocine Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Biotechnology
Market cap:: $17.81M
Revenue:: $190,100

LPCN earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Lipocine Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Themes

Related & Connected

Connected companies and research pages from the AlphaOS knowledge graph.